Generally, CD8+ T cells are considered as effector cells to destroy cancer cells, whereas the roles of anti-tumor CD4+ T cells are to provide CD4-help to other immune effector cells such as CD8+ T cells through cytokine production and CD40-CD40L ligation. This evidence concerns the gene CD40LG and cancer.